London Health Sciences Center

London, Ontario NGA4L6

3 studies enrolling now · 39 studies all time

What they study most

Acute Coronary Syndrome, Acute Kidney Injury, Adenoid Cystic Carcinoma, Advanced Non-clear Cell Renal Cell Carcinoma, Amyloidosis, Amyotrophic Lateral Sclerosis (ALS), Arteriovenous Malformations, Cerebral, Becker Muscular Dystrophy, Blunt Thoracic Aortic Injury, Carcinoma, Renal Cell, Cardiovascular Disease, Cardiovascular Diseases

Studies at this site

• Study of COYA 302 for the Treatment of ALS — Recruiting now
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures — Recruiting now
• A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy — Running, not enrolling
• An Open-label Study of XEN1101 in Epilepsy — Enrolling by invitation
• Setrusumab vs Placebo for Osteogenesis Imperfecta — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis — Completed
• CardiAMP™ Cell Therapy for Heart Failure Trial — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke — Stopped early
• SAHaRA: A Randomized Controlled Trial — Completed
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
• A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations — Completed
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• Study to Determine if the Valiant Stent Graft is Safe and Effective in Treating Patients Who Have a Blunt Thoracic Aortic Injury — Completed
• Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass — Status unconfirmed
• Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD) — Completed
• Evaluating the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures — Completed
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• Transfusion Requirements in Cardiac Surgery III — Completed
• Evaluation of ClearLLab Leukemia and Lymphoma Panels — Completed
• Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma — Completed
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) — Completed
• Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer — Completed
• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs — Completed
• A Randomized Trial of Unruptured Brain AVMs — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas — Completed
• Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial — Completed
• Effectiveness of Mexiletine for Treating People With Non-Dystrophic Myotonia — Completed
• Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure — Completed
• Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension — Completed
• A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer — Stopped early
• A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 — Completed
• PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma — Completed
• Parkinson's Research: The Organized Genetics Initiative — Completed
• Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — Completed
• Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection — Completed
• Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients — Completed